Cell Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cell Therapy stocks.

Cell Therapy Stocks Recent News

Date Stock Title
Apr 19 CELU Celularity receives Nasdaq notice regarding late Form 10-K filing
Apr 19 CELU Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Apr 19 CLDI Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
Apr 18 CELU Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024
Apr 18 ALLO To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Apr 16 CGEM Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity
Apr 16 CGEM UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
Apr 16 BRTX BioRestorative gains as FDA clears amendment to study on cell therapy candidate
Apr 16 CLDI Calidi Biotherapeutics slumps 54%, prices $6.1M equity
Apr 16 CLDI Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
Apr 16 BRTX BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
Apr 16 CGEM Cullinan Therapeutics expands into autoimmune diseases
Apr 16 CGEM Cullinan Therapeutics gets $280M via oversubscribed private placement
Apr 16 CGEM Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
Apr 16 CGEM Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
Apr 16 CGEM Cullinan changes name, pivots to autoimmune disease
Apr 15 CELU Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
Apr 14 BRTX 10 Micro-Cap Healthcare Stocks Insiders Are Buying
Cell Therapy

Cell therapy (also called cellular therapy or cytotherapy) is therapy in which cellular material is injected into a patient; this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
Cell therapy originated in the nineteenth century when scientists experimented by injecting animal material in an attempt to prevent and treat illness. Although such attempts produced no positive benefit, further research found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation.Today two distinct categories of cell therapy are recognized.The first category is cell therapy in mainstream medicine. This is the subject of intense research and the basis of potential therapeutic benefit. Such research can be controversial when it involves human embryonic material.
The second category is in alternative medicine, and perpetuates the practice of injecting animal materials in an attempt to cure disease. This practice, according to the American Cancer Society, is not backed by any medical evidence of effectiveness, and can have deadly consequences.

Browse All Tags